Astal Laboratories Complete Financial Statements
ASTALLTD • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Astal Laboratories (ASTALLTD).
Downloads include all available records across all periods.
For market performance, see the
ASTALLTD stock price today
.
Profitability Ratios
Net Profit Margin
14.06%
2025 data
EBITDA Margin
20.31%
2025 data
Operating Margin
20.00%
2025 data
Return on Assets
14.29%
2025 data
Return on Equity
25.00%
2025 data
Balance Sheet Ratios
Current Ratio
46.00
2025 data
Debt to Equity
1.75
2025 data
Equity Ratio
57.14%
2025 data
Asset Turnover
1.02
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+57.8%
Year-over-Year
Net Profit Growth
+11.1%
Year-over-Year
EBITDA Growth
+15.4%
Year-over-Year
Expense Growth
+65.4%
Year-over-Year
Assets Growth
+70.3%
Year-over-Year
Equity Growth
+56.5%
Year-over-Year
Liabilities Growth
+70.3%
Year-over-Year
Operating Cash Flow Growth
-116.7%
Year-over-Year
Investing Cash Flow Growth
-33.3%
Year-over-Year
Financing Cash Flow Growth
-83.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 64 | 24 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 86 | 52 | 23 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 15 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 16.00% | 20.00% | 5.00% | -4.00% | 0.00% | 12.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 10 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 9.90 | 9.08 | 1.55 | 0.04 | -0.04 | 0.02 | -0.07 | -0.21 | -0.02 | 0.01 | 0.02 | 0.46 |
Related Pages for Astal Laboratories
Additional stock information and data for ASTALLTD
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 63 | 37 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Current Assets | 46 | 27 | 6 | 0 | 0 | 5 | 5 | 5 | 5 | 5 | 5 |
| Fixed Assets | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 52 | 36 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| LIABILITIES | |||||||||||
| Total Liabilities | 63 | 37 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Current Liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 36 | 23 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Share Capital | 10 | 10 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 22 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -13 | -6 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -8 | -6 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 3 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -17 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |